Enliven Therapeutics CFO Stock Sale: What It Means for Investors
A recent significant stock transaction by Enliven Therapeutics, Inc. (NASDAQ:ELVN) Chief Financial Officer Benjamin Hohl has drawn attention, as he divested a substantial portion of his holdings….